Successful discontinuation of antifungal secondary prophylaxis in AIDS-related cryptococcosis;Interrupción exitosa de la profilaxis secundaria antifúngica en la criptococosis asociada al SIDA

Revista Argentina de Microbiologia

Volumn 36, Issue 3, 2004, Pages 113-117

  Negroni, R ^a   Helou, S H ^a   LoPez Daneri G ^a   Robles, A M ^a   Arechavala, A I ^a   Bianchi, M H ^a  

^a HOSPITAL F J MUÑIZ   (Argentina)

Author keywords

AIDS; Cryptococcosis; Secondary prophylaxis discontinuation

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; FLUCONAZOLE; FUNGUS ANTIBODY; FUNGUS ANTIGEN; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AIDS RELATED COMPLEX; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CRYPTOCOCCOSIS; DETERIORATION; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; FEVER; HEALTH STATUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; LYMPHOCYTE COUNT; MALE; MENINGISM; PROPHYLAXIS; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CRYPTOCOCCOSIS; FEMALE; FLUCONAZOLE; HUMANS; IMMUNOCOMPETENCE; MALE; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGED; RECURRENCE; VIRAL LOAD; WITHHOLDING TREATMENT;

EID: 8344222863     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Aberg JA, Price RW, Heeren DM, Bredt B (2002) A pilot study of de discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immuno-deficiency syndrome, following immunologic response to antiretroviral therapy. J. Infect. Dis. 185: 1179-1182.
2. Arechavala A, Robles AM, Negroni R, Bianchi M, Taborda A (1993) Valor de los métodos directo e indirecto de diagnostico en las micosis asociadas al SIDA. Rev. Inst. Med. Trop. Sao Paulo 35: 163-169.
3. Bava AJ (1993) Criptococosis en la Republica Argentina. Tesis de Doctorado. Rev. Argent. Micol. 16: 3-41.
4. Bianchi M, Robles AM, Vitale R, Helou S, Arechavala A, Negroni R (2000) The usefulness of bloodcultures in the diagnosis of AIDS-related systemic mycoses: evaluation of a manual lysis-centrifugation method. Med. Mycol. 38: 77-80.
5. Caligari Costa L, Dalla Negra M, Ferreria MS, Kaplan J, Negroni R, Weissenbacher M (2003) Normas para la prevención de la infecciones oportunistas en las personas infectadas por el VIH. Organización Panamericana de la Salud. Reunion de expertos realizada en Montevideo. Julio. En prensa.
6. Casadevall A, Perfect J (1998) Cryptococcus neoformans. ASM Press, Washington, D.C.
7. da ed, FUNDAI, Buenos Aires, p. 53-96.
8. rd ed, Lippincott Williams & Wilkins, Phialdelphia, p. 91-103.
9. Helou S, Robles AM, Arechavala A, Bianchi M, Negroni R (1999) Criptococosis respiratoria en pacientes VIH positivos. Rev. Iberoamer. Micol. 16: 126-129.
10. Larsen RA, Leal ME, Chan LS (1990) Fluconazole compared with amphotericin B plus flucytosina for cryptococcal meningitis in AIDS. Ann. Intern. Med. 113: 183-187.
11. Mussini C, Pezzotti P, Miró J.M, Martínez E et al (2004) Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study. Clin. Inf. Dis. 38: 565-571.
12. Mwokolo NC, Fisher M, Gazzard BG, Nelson MR (2001) Cessation of secondary prophylaxis in patients with Cryptococcosis. AIDS 15: 1438-1439.
13. Negroni R, Arechavala A, Robles AM, Bianchi M, Bava AJ, Helou S (1995) Revisión clínica y evolución terapéutica de pacientes con criptococosis asociada al SIDA. Rev. Iberoamer. Micol. 12: 12-15.
14. da ed, FUNDAI, Buenos Aires, p. 301-324.
15. nd ed, p. 1045-1057.
16. Norman GR, Streiner DL (1996) Bioestadística. Harcourt Brace, España.
17. Powderly WG (1996) Recent advances in the management of cryptococcal meningitis in patients with AIDS. Clin. Infect. Dis. 22 (Suppl. 2): S119-127.
18. Rollot F, Bossi P, Tubiana R, Caumes E, Zeller V, Katlam C, Briscaire F (2001) Discontinuation of secondary prophylaxis against cryptococcosis in patients with AIDS receiving high active antiretroviral therapy. AIDS 15: 1448-1449.
19. Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharley PK, Thompson SE, Sugar AM, Tuazon CV, Fischer JF, Hyslop N, Jacobson J.M, Hafner R, Dismukes WE and the NIALD Mycoses Study Group, and AIDS Clinical Trial Group (1992) Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N. Engl. J. Med. 326: 83-89.
20. Sheng WH, Hung CC, Chen MY, Hseik SM, Chang SC (2002) Successful discontinuation of fluconazole as secondary prophylaxis for cryptococcosis in AIDS-patients responding to high active antiretroviral therapy. Intern. J. STD & AIDS 13: 702-705.
21. Taborda A, Negroni R, Arechavala A, Rubles AM (1993) Criptococosis asociada al SIDA. Estudio retrospectivo de tres terapéuticas antifúngicas en 43 casos. Rev. Iberoamer. Micol. 10: 10-13.
22. Van der Horst CN, Saag MS, Gretchen AG, Hamill RJ et al (1997) Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 337: 15-21.
23. Van Eiden LJR, Walenkamp AME, Lipovsky MM et al (2000) Decreasing number of patients with cryptococcosis in the Netherlands in the era of highly active antiretroviral therapy. AIDS 14: 2787-2800.
24. Vibhagool A, Sungkamparph S, Mootsikapun P, Chetchotisakd P, Tonsuphaswadikul S, Bowonwatamuwong C, Ingsathit A (2003) Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus infected patients treated with high active antiretroviral therapy: a prospective multicenter, randomized study. Clin. Infect. Dis. 36: 1329-1331.